A 3D lymph node model for chronic lymphocytic leukaemia recapitulates microenvironmental features and drug response in vitro
Disease Models & Mechanisms · 01.06.2026 · 19 (6)
DOI: 10.1242/dmm.052731 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Models & Mechanisms, online erschienen am 31.03.2026. Verfasst von Daniela Belloni und 12 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Malignant B Cells Biology and 3D Modelling, Division of Experimental Oncology, IRCCS Ospedale San Raffaele, Comprehensive Cancer Center, 2013…. Hauptthemen laut MEDLINE: Leukemia, Lymphocytic, Chronic, B-Cell, Tumor Microenvironment, Lymph Nodes, Models, Biological. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione AIRC per la ricerca sul cancro ETS, European Hematology Association, European Commission.
Abstract (Originalsprache)
Chronic lymphocytic leukaemia (CLL) cells circulate between the blood, bone marrow (BM) and lymphoid organs, where interactions with the lymph node (LN) microenvironment enhance their survival, proliferation and drug resistance. Most in vitro models fail to reproduce the spatial and cellular complexity of the LN niche, limiting studies of tissue-specific drug responses. To address this, we developed a 3D LN model using a gelatine scaffold and a clinorotator bioreactor previously validated for a BM system. The scaffold was seeded with human lymphatic fibroblasts and endothelial cells, which deposited extracellular matrix and supported patient-derived CLL cell viability and proliferation. Consistent with in vivo observations, CLL cells within the scaffold downregulated the chemokine receptor CXCR4, further reduced upon proliferative stimulation. Final validation involved treatment with targeted therapies: the BCL-2 antagonist venetoclax and the BTK inhibitor ibrutinib. Venetoclax treatment revealed greater CLL protection within the LN environment than in BM, whereas the mobilizing effect of ibrutinib was comparable between these two niches. This 3D LN model offers an effective ex vivo platform for studying microenvironment–tumour interactions and tissue-specific drug responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unit of Malignant B Cells Biology and 3D Modelling, Division of Experimental Oncology, IRCCS Ospedale San Raffaele, Comprehensive Cancer Center, 20132 Milan, Italy.
- Unit B Cell Neoplasia, Division of Experimental Oncology, IRCCS Ospedale San Raffaele, Comprehensive Cancer Center, 20132 Milan, Italy.
- Medical School, Università Vita-Salute San Raffaele, 20132 Milan, Italy.
- Pathology Unit, IRCCS Ospedale San Raffaele, 20132 Milan, Italy.
- Strategic Research Program on CLL, IRCCS Ospedale San Raffaele, 20132 Milan, Italy.
ORCID-Profile: Daniela Belloni, Cristina Scielzo
Förderung
- Fondazione AIRC per la ricerca sul cancro ETS
- European Hematology Association
- European Commission
- NextGenerationEU
- Ospedale San Raffaele
Zitieren
APA
Belloni, D., Barozzi, D., Milani, G., Barbaglio, F., Puthukkunnath, A. R., Ranghetti, P., Perotta, E., Musco, T., Sampietro, M., Ponzoni, M., Scarfò, L., Ghia, P., & Scielzo, C. (2026). A 3D lymph node model for chronic lymphocytic leukaemia recapitulates microenvironmental features and drug response in vitro. Disease Models & Mechanisms, 19(6). https://doi.org/10.1242/dmm.052731
Vancouver
Belloni D, Barozzi D, Milani G, Barbaglio F, Puthukkunnath AR, Ranghetti P, et al. A 3D lymph node model for chronic lymphocytic leukaemia recapitulates microenvironmental features and drug response in vitro. Disease Models & Mechanisms. 2026;19(6). doi:10.1242/dmm.052731
BibTeX
@article{Belloni2026,
author = {Belloni, Daniela and Barozzi, Dafne and Milani, Giulia and Barbaglio, Federica and Puthukkunnath, Aswin Raj and Ranghetti, Pamela and Perotta, Eleonora and Musco, Teresa and Sampietro, Marta and Ponzoni, Maurilio and Scarfò, Lydia and Ghia, Paolo and Scielzo, Cristina},
title = {A 3D lymph node model for chronic lymphocytic leukaemia recapitulates microenvironmental features and drug response in vitro},
journal = {Disease Models & Mechanisms},
year = {2026},
volume = {19},
number = {6},
doi = {10.1242/dmm.052731}
}
EUVIMED